tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Is ORN a Buy, Before Earnings?
Pre-EarningsIs ORN a Buy, Before Earnings?
1M ago
Oryzon Genomics Advances Phase III Trial for BPD Treatment
PremiumCompany Announcements
Oryzon Genomics Advances Phase III Trial for BPD Treatment
2M ago
Oryzon Genomics Advances Phase III Trial for BPD Treatment
PremiumCompany Announcements
Oryzon Genomics Advances Phase III Trial for BPD Treatment
2M ago
Oryzon Genomics Announces 2025 Shareholders Meeting
PremiumCompany Announcements
Oryzon Genomics Announces 2025 Shareholders Meeting
3M ago
Oryzon Genomics Strengthens Financial Position and Advances Clinical Trials in Q1 2025
PremiumCompany Announcements
Oryzon Genomics Strengthens Financial Position and Advances Clinical Trials in Q1 2025
4M ago
Oryzon Genomics Secures €13.26 Million for VANDAM Project under IPCEI
PremiumCompany AnnouncementsOryzon Genomics Secures €13.26 Million for VANDAM Project under IPCEI
4M ago
ORN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ORN Upcoming Earnings Report: What to Expect?
4M ago
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
Premium
Company Announcements
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
4M ago
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
PremiumCompany Announcements
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
4M ago
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
PremiumCompany Announcements
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
4M ago
Oryzon Genomics SA Strengthens Governance and Financial Strategy
PremiumCompany Announcements
Oryzon Genomics SA Strengthens Governance and Financial Strategy
6M ago
Oryzon Genomics SA Announces Directors’ Remuneration Policy for 2023-2025
PremiumCompany Announcements
Oryzon Genomics SA Announces Directors’ Remuneration Policy for 2023-2025
6M ago
Oryzon Genomics Calls Extraordinary Shareholders Meeting for 2025
PremiumCompany AnnouncementsOryzon Genomics Calls Extraordinary Shareholders Meeting for 2025
7M ago
Oryzon Genomics Schedules Extraordinary Shareholders Meeting
Premium
Company Announcements
Oryzon Genomics Schedules Extraordinary Shareholders Meeting
7M ago
Oryzon Genomics to List New Shares on Spanish Exchanges
Premium
Company Announcements
Oryzon Genomics to List New Shares on Spanish Exchanges
9M ago
Oryzon Genomics Advances Clinical Trials Amid Financial Adjustments
PremiumCompany Announcements
Oryzon Genomics Advances Clinical Trials Amid Financial Adjustments
10M ago
ORN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ORN Upcoming Earnings Report: What to Expect?
10M ago
Oryzon Genomics Advances Vafidemstat into Phase III
PremiumCompany Announcements
Oryzon Genomics Advances Vafidemstat into Phase III
11M ago
Oryzon Genomics Announces Bond-to-Share Conversion
PremiumCompany Announcements
Oryzon Genomics Announces Bond-to-Share Conversion
11M ago
Oryzon Genomics Announces Positive BPD Trial Results
PremiumCompany AnnouncementsOryzon Genomics Announces Positive BPD Trial Results
11M ago
Oryzon Genomics Announces Bond-to-Share Conversion
Premium
Company Announcements
Oryzon Genomics Announces Bond-to-Share Conversion
1y ago
ORN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ORN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >